PITTSBURGH--(BUSINESS WIRE)--Cellumen, Inc., a discovery toxicology company, today announced the company has been selected by the Drug Safety Executive Council (DSEC) as one of eight Signature Partners working to improve drug safety by addressing industry challenges and regulatory practices.
